Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxi-Rio
NCT07500415Recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of doxycycline in sexually transmitted infection (STI), syphilis, gonorrhea and 1 more, sponsored by Fundação Oswaldo Cruz. Primary endpoint: Incidence of bacterial sexually transmitted infections at 48 weeks. Started Oct 2025; status: recruiting.
02
Drugs
doxycycline
03
Conditions
sexually transmitted infection (STI)syphilisgonorrheachlamydia infection
Beyond the preview
Go deeper on NCT07500415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07500415.